Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT00723437Phase 4Completed
Phase 4, open-label, single-arm trial of acitretin in nail psoriasis, sponsored by Istituti Fisioterapici Ospitalieri. Primary endpoint: Nail Psoriasis Severity Index at 6 months. Started Jan 2005; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT00723437.